Russia Sanctions Bill Revives India Tariff Risk for SIG and AMRX

The Russia sanctions bill passed by the US House on September 16, 2026 revives India tariff risk for US importers. The 262-159 vote passed the Lindsey O. Graham Sanctioning Russia and Iran Act of 2026, authorizing tariffs of up to 100% on countries that buy Russian oil and gas. The cost would fall on US importers of Indian goods.[1]

The bill has cleared Congress and goes to the President for signature.[1] The tariff language names no country: a Senate amendment mandates secondary tariffs of up to 100% on goods imported from "the top five largest buyers of Russian crude oil and natural gas."[2] The House Rules Committee voted 3-7 against an amendment naming India, China, Turkiye and others, leaving the list to the executive branch.[3]

Background: what a secondary tariff is

A secondary tariff is not a tax on Russia. It is a duty on all goods shipped to the US from a country that buys Russian oil. US Customs collects it from the US importer at entry, so it shows up first in cost of goods sold.

US tariffs on India had been falling this year. The earlier tariffs were imposed by executive order under IEEPA. After the Supreme Court ruled them illegal, importers began recovering payments; Deere recovered $272 million in June 2026.[4] USTR then cut the additional Section 301 tariff on Indian imports from 12.5% to 10% and exempted 45% of India's exports.[5] This time the authority is a statute, which that ruling does not reach.

India is hard to keep out of the top five. Its imports of Russian crude hit a record 2.8 million barrels per day in July 2026, 55.5% of its total crude imports, and fell to 2.08 million barrels per day in August.[6]

How the tariff moves from customs into importers' costs

The first link is the design of the tool. Existing tariffs carry product exemptions: the April 2, 2026 Section 232 pharmaceutical action exempts generics, biosimilars and their APIs, and the Section 301 action exempts 45% of India's exports.[5][7] A secondary tariff applies by country to all goods and has no product exemption to inherit.

The second link is who pays: the US importer, at entry. The pressure lands in cost of goods sold and gross margin at companies selling Indian-made goods in the US.

The third link is timing. The duty is paid at entry but reaches the income statement only as inventory turns: about four times a year for generic drugs and about 1.3 times for jewelry.[10]

Upstream, if India swaps Russian barrels for Atlantic-basin or US Gulf supply, longer voyages support tanker rates. On September 16, Frontline (FRO) rose 4.03% and DHT rose 4.07%.[10]

Companies that could be affected

Signet Jewelers (SIG) is a jewelry retailer focused on the US market. FY2026 revenue was $6,813.6 million, with 90.27% from the US.[10] It sits at the importer link: its 10-K says that historically "approximately half of the finished merchandise and loose diamonds that Signet has purchased have been imported from India."[8]

Based on FY2026 cost of sales of $4,119.0 million, Indian-origin merchandise cost is an estimated ~$1.65 billion, against FY2027 adjusted operating income guidance of $535 million to $605 million.[8][9] Even a 10-point realized increase after re-sourcing, about $165 million, would exceed a quarter of operating income, so margins could come under pressure. Management has said it can "mitigate the majority of the higher tariffs through strategic sourcing initiatives"; the next 10-Q will show whether the "approximately half" India disclosure changes.[8] For now Signet still benefits from $7 million to $9 million of tariff refunds in Q3 FY2027.[9]

Amneal Pharmaceuticals (AMRX) is a US generic drug company with FY2025 revenue of $3,018.8 million.[10] It also sits at the importer link: its 10-Q says "the great majority of our net sales rely on finished dosage forms ('FDF') or active pharmaceutical ingredients ('API') produced in the U.S. or India."[7]

Amneal does not disclose India-origin cost of goods sold separately. The closest measure is long-lived assets: India held 32.1% of the $550.3 million total at year-end 2025.[7] Applied to $1,882.7 million of cost of goods sold, that suggests about $604 million could involve India, against FY2025 operating income of $423.1 million.[10] Generics are priced under multi-year contracts, so pass-through is hard in the first year; even a 25-point realized increase, about $151 million, would approach 40% of operating income. For scale, management sized flood damage at one Gujarat plant at $20 million of 2026 results.[9] The 32.1% figure is an asset-based proxy; the real exposure awaits company disclosure.

What to watch

First, the implementing document: whether an executive order designating the top five buyers follows the signature, whether India is on it, and whether it exempts jewelry (HTS 71) and finished dosage forms (HTS 30). The chain holds only if India is named with no product carve-out.

Second, two earnings calls: Amneal on October 29, 2026, for whether management quantifies India-origin costs for the first time, and Signet on December 1, 2026, for whether refunds reverse or a tariff accrual appears.[10]

Third, monthly data. India's merchandise exports to the US were $8.4 billion in August, up 21.83% year over year.[11] If Russian crude imports keep falling toward zero, India drops out of the top five and the chain fails.

Other ways the thesis breaks: the President does not sign, or the list excludes India; an India-US trade deal lands first, after India's Commerce Secretary said on September 9 the deal is "more or less" finalized[12]; the implementing order keeps existing exemptions, which would remove the Amneal leg; or Signet re-sources faster than the duty lands. Moving Amneal's production to US plants requires prior FDA approval and is unlikely within four quarters.[7]

The designation order is the key event and could come within weeks. The tanker leg would react first; the importer leg depends on inventory turns and company disclosure.

This piece only surfaces possibly overlooked transmission chains - not stock recommendations.

Sources

[1] New York Post · 2026-09-16 · News · https://nypost.com/2026/09/16/us-news/house-passes-lindsey-graham-sanctions-act-sends-anti-russia-bill-to-trumps-desk/ [2] Times of Oman · 2026-09-15 · News · https://timesofoman.com/article/176955-us-senate-amendment-mandates-100-secondary-tariffs-on-top-five-russian-oil-importers-including-india [3] OneIndia · 2026-09-16 · News · https://www.oneindia.com/international/days-after-putin-s-brics-visit-us-moves-toward-100-tariff-powers-over-russian-oil-buyers-india-in-8206227.html [4] Supply Chain Dive · 2026-06-04 · News · https://www.supplychaindive.com/news/deere-recovers-272m-in-tariff-refunds/821818/ [5] Trak.in · 2026-07-26 · News · https://trak.in/stories/45-indian-exports-get-relief-as-us-reduces-tariff-to-10/ [6] OilPrice · 2026-08-31 · News · https://oilprice.com/Energy/Crude-Oil/Russian-Oil-Is-No-Longer-Indias-Easy-Bargain.html [7] Amneal Pharmaceuticals · 10-Q 2026-05-07, 10-K 2026-02-27 · Company filings [8] Signet Jewelers · 10-K 2026-03-19, 10-Q 2025-12-05 · Company filings [9] Drillr earnings call summaries · SIG 2026-09-09, AMRX 2026-07-30 [10] Drillr financial, price and earnings calendar data · 2026-09-16 [11] Economic Times · 2026-09-15 · News · https://economictimes.indiatimes.com/news/economy/foreign-trade/indias-exports-surge-to-key-markets-us-shipments-rise-21-83-china-52-35-singapore-161-in-august-check-the-latest-trade-data/articleshow/134268586.cms [12] Economic Times · 2026-09-09 · News · https://economictimes.indiatimes.com/news/economy/foreign-trade/india-us-trade-deal-more-or-less-finalised-framework-for-preferential-access-being-worked-out-commerce-secretary-rajesh-agarwal/articleshow/133960687.cms